BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 28744835)

  • 21. Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe.
    Peng ZW; Liang HH; Chen MS; Zhang YJ; Li JQ; Zhang YQ; Lau WY
    Eur J Surg Oncol; 2008 Feb; 34(2):166-72. PubMed ID: 17851020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Efficacy of Laparoscopic Radiofrequency Ablation in Early Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Tan HY; Gong JF; Yu F; Tang WH; Yang K
    J Laparoendosc Adv Surg Tech A; 2019 Jun; 29(6):770-779. PubMed ID: 30801203
    [No Abstract]   [Full Text] [Related]  

  • 23. Radiofrequency ablation versus surgical resection for intrahepatic hepatocellular carcinoma recurrence: a meta-analysis.
    Chen X; Chen Y; Li Q; Ma D; Shen B; Peng C
    J Surg Res; 2015 May; 195(1):166-74. PubMed ID: 25724768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas.
    Kim GA; Shim JH; Kim MJ; Kim SY; Won HJ; Shin YM; Kim PN; Kim KH; Lee SG; Lee HC
    Br J Surg; 2016 Jan; 103(1):126-35. PubMed ID: 26572697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?
    Huang J; Yan L; Wu H; Yang J; Liao M; Zeng Y
    J Surg Res; 2016 Jan; 200(1):122-30. PubMed ID: 26277218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Sohn W; Paik YH; Lee MW; Rhim H; Lim HK; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Scand J Gastroenterol; 2014 Mar; 49(3):373-80. PubMed ID: 24354931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous radiofrequency ablation versus partial hepatectomy for small centrally located hepatocellular carcinoma.
    Guo WX; Sun JX; Cheng YQ; Shi J; Li N; Xue J; Wu MC; Chen Y; Cheng SQ
    World J Surg; 2013 Mar; 37(3):602-7. PubMed ID: 23212793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Facciorusso A; Del Prete V; Antonino M; Crucinio N; Neve V; Di Leo A; Carr BI; Barone M
    Dig Liver Dis; 2014 Nov; 46(11):1014-9. PubMed ID: 25085684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma (≤3 cm).
    Santambrogio R; Chiang J; Barabino M; Meloni FM; Bertolini E; Melchiorre F; Opocher E
    Ann Surg Oncol; 2017 Jan; 24(1):257-263. PubMed ID: 27581608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion.
    Ng KK; Poon RT; Lam CM; Yuen J; Tso WK; Fan ST
    Br J Surg; 2006 Apr; 93(4):440-7. PubMed ID: 16470712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of percutaneous radiofrequency ablation and CyberKnife(®) for initial solitary hepatocellular carcinoma: A pilot study.
    Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kishimoto Y; Okubo Y; Makino H; Tsukamoto N; Igarashi Y; Sumino Y
    World J Gastroenterol; 2015 Dec; 21(48):13490-9. PubMed ID: 26730160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoscopic versus open radiofrequency ablation for treatment of small hepatocellular carcinoma.
    Sakoda M; Ueno S; Iino S; Minami K; Ando K; Kawasaki Y; Kurahara H; Mataki Y; Maemura K; Shinchi H; Natsugoe S
    World J Surg; 2013 Mar; 37(3):597-601. PubMed ID: 23192169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.
    Tiong L; Maddern GJ
    Br J Surg; 2011 Sep; 98(9):1210-24. PubMed ID: 21766289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation for 110 malignant liver tumours: preliminary results on percutaneous and surgical approaches.
    Wong J; Lee KF; Lee PS; Ho SS; Yu SC; Ng WW; Cheung YS; Tsang YY; Ling E; Lai PB
    Asian J Surg; 2009 Jan; 32(1):13-20. PubMed ID: 19321397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation.
    Yazici P; Akyuz M; Yigitbas H; Dural C; Okoh A; Aydin N; Berber E
    Surg Endosc; 2017 Mar; 31(3):1269-1274. PubMed ID: 27444839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma.
    Hsieh CB; Chang HM; Chen TW; Chen CJ; Chan DC; Yu JC; Liu YC; Chang TM; Shen KL
    World J Gastroenterol; 2004 Feb; 10(4):505-8. PubMed ID: 14966906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.